The purpose of this study is to learn about the safety, efficacy and utility of a medical device called the Cook® Venous Valve System. This device, percutaneously placed in the leg, is meant to help the blood flow correctly through the veins in the leg.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
4
The Cook® Venous Valve is a permanent prosthetic, bicuspid, one-way flow valve designed to be percutaneously implanted into the peripheral deep venous system. The Cook® Venous Valve Delivery System is used to percutaneously deliver the Cook® Venous Valve into the deep venous system.
Angiosur S.A.S.
Antioquia, Colombia
Clínica de La Costa S.A.S.
Barranquilla, Colombia
Fundacion Oftalmologica De Santander
Santander, Colombia
Freedom from major adverse events in the first 30 days
The primary safety endpoint is freedom from major adverse events (MAE) in the first 30 days, where MAE is defined as: death, clinically-driven reintervention, bleeding requiring transfusion, flow limiting dissection of the target vessel, or clinically significant deep vein thrombosis (DVT), pulmonary embolism, or device migration.
Time frame: 30 days after enrollment
Freedom from MAE at three months, six months, and 12 months
The secondary safety endpoint is freedom from MAE at three months, six months, and 12 months.
Time frame: Three months, six months, and 12 months after enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.